P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN PATIENTS WITH MCL DURING LENALIDOMIDE-BASED THERAPY

• S. Husby,
• C. Bæch-Laursen,
• F. Favero,
• J. S. Jespersen,
• C. W. Eskelund,
• M. Hutchings,
• L. B. Pedersen,
• C. U. Niemann,
• J. Weischenfeldt,
• C. Geisler,
• R. Räty,
• T. S. Larsen,
• A. Kolstad,
• M. Jerkeman,
• K. Grønbæk

Affiliations

S. Husby

1 Hematology, Rigshospitalet, Copenhagen

C. Bæch-Laursen

2 Hematology, Rigshospitalet, Copenhagen N

F. Favero

3 Biotech Research & Innovation Center (BRIC), University of Copenhagen, Copenhagen

J. S. Jespersen

4 Biotech Research & Innovation Center (BRIC), University of Copenhagen, Copenhagen N, Denmark

C. W. Eskelund

1 Hematology, Rigshospitalet, Copenhagen

M. Hutchings

1 Hematology, Rigshospitalet, Copenhagen

L. B. Pedersen

1 Hematology, Rigshospitalet, Copenhagen

C. U. Niemann

1 Hematology, Rigshospitalet, Copenhagen

J. Weischenfeldt

3 Biotech Research & Innovation Center (BRIC), University of Copenhagen, Copenhagen

C. Geisler

1 Hematology, Rigshospitalet, Copenhagen

R. Räty

5 Hematology, Helsinki University Hospital, Helsinki, Finland

T. S. Larsen

6 Hematology, Odense University Hospital, Odense, Denmark

A. Kolstad

7 Oncology, Sykehuset Innlandet, Lillehammer, Norway

M. Jerkeman

8 Oncology, Lund University Hospital, Lund, Sweden

K. Grønbæk

1 Hematology, Rigshospitalet, Copenhagen